Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

by Ulf Andreasson, Kaj Blennow, Henrik Zetterberg
Published 2016-01-01

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

by Annika Öhrfelt, Per Johansson, Anders Wallin, Ulf Andreasson, Henrik Zetterberg, Kaj Blennow, Johan Svensson
Published 2016-07-01

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus

by Karolina Minta, Anna Jeppsson, Gunnar Brinkmalm, Erik Portelius, Henrik Zetterberg, Kaj Blennow, Mats Tullberg, Ulf Andreasson
Published 2021-05-01

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.

by Per Johansson, Erik G Almqvist, Anders Wallin, Jan-Ove Johansson, Ulf Andreasson, Kaj Blennow, Henrik Zetterberg, Johan Svensson
Published 2017-01-01

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.

by Mikko Hölttä, Oskar Hansson, Ulf Andreasson, Joakim Hertze, Lennart Minthon, Katarina Nägga, Niels Andreasen, Henrik Zetterberg, Kaj Blennow
Published 2013-01-01

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology

by Pei‐Ning Wang, Kun‐Ju Lin, Huei‐Chun Liu, Ulf Andreasson, Kaj Blennow, Henrik Zetterberg, Shieh‐Yueh Yang
Published 2020-01-01

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

by Christoffer Rosén, Carl-Henrik Andersson, Ulf Andreasson, José L. Molinuevo, Maria Bjerke, Lorena Rami, Albert Lladó, Kaj Blennow, Henrik Zetterberg
Published 2014-07-01

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

by Maria Bjerke, Erik Portelius, Lennart Minthon, Anders Wallin, Henrik Anckarsäter, Rolf Anckarsäter, Niels Andreasen, Henrik Zetterberg, Ulf Andreasson, Kaj Blennow
Published 2010-01-01

Corrigendum to: “Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study” [EBioMedicine 3 (216) 135–140...

by Magnus Gisslén, Richard W. Price, Ulf Andreasson, Niklas Norgren, Staffan Nilsson, Lars Hagberg, Dietmar Fuchs, Serena Spudich, Kaj Blennow, Henrik Zetterberg
Published 2016-05-01

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

by Magnus Gisslén, Richard W. Price, Ulf Andreasson, Niklas Norgren, Staffan Nilsson, Lars Hagberg, Dietmar Fuchs, Serena Spudich, Kaj Blennow, Henrik Zetterberg
Published 2016-01-01

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

by Piotr Lewczuk, Natalia Ermann, Ulf Andreasson, Christian Schultheis, Jana Podhorna, Philipp Spitzer, Juan Manuel Maler, Johannes Kornhuber, Kaj Blennow, Henrik Zetterberg
Published 2018-07-01

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.

by Per Johansson, Erik G Almqvist, Jan-Ove Johansson, Niklas Mattsson, Ulf Andreasson, Oskar Hansson, Anders Wallin, Kaj Blennow, Henrik Zetterberg, Johan Svensson
Published 2013-01-01

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

by Nicholas C. Cullen, Henrik Zetterberg, Philip S. Insel, Bob Olsson, Ulf Andreasson, the Alzheimer’s Disease Neuroimaging Initiative, Kaj Blennow, Oskar Hansson, Niklas Mattsson‐Carlgren
Published 2020-09-01

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury

by Karolina Minta, Gunnar Brinkmalm, Faiez Al Nimer, Eric P. Thelin, Fredrik Piehl, Mats Tullberg, Anna Jeppsson, Erik Portelius, Henrik Zetterberg, Kaj Blennow, Ulf Andreasson
Published 2020-10-01

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease

by Annika Öhrfelt, Ulf Andreasson, Adam Simon, Henrik Zetterberg, Åke Edman, William Potter, Daniel Holder, Viswanath Devanarayan, Jeffrey Seeburger, A. David Smith, Kaj Blennow, Anders Wallin
Published 2011-01-01

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and Univ...

by Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andreasson, Erik Portelius, Nicholas J. Ashton, Kaj Blennow, Michael Schöll, Ross W. Paterson, Jonathan M. Schott, Henrik Zetterberg
Published 2020-02-01

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system.

by Niklas Mattsson, Lawrence Rajendran, Henrik Zetterberg, Mikael Gustavsson, Ulf Andreasson, Maria Olsson, Gunnar Brinkmalm, Johan Lundkvist, Laura H Jacobson, Ludovic Perrot, Ulf Neumann, Herman Borghys, Marc Mercken, Deborah Dhuyvetter, Fredrik Jeppsson, Kaj Blennow, Erik Portelius
Published 2012-01-01

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology

by Sarah Westwood, Benjamine Liu, Alison L. Baird, Sneha Anand, Alejo J. Nevado-Holgado, Danielle Newby, Maria Pikkarainen, Merja Hallikainen, Johanna Kuusisto, Johannes R. Streffer, Gerald Novak, Kaj Blennow, Ulf Andreasson, Henrik Zetterberg, Ulf Smith, Markku Laakso, Hilkka Soininen, Simon Lovestone
Published 2017-04-01